TherapeuticsMD Balance Sheet - Annual (NASDAQ:TXMD)

Add to My Stocks
$6.14 $0.14 (2.23%) TXMD stock closing price Sep 17, 2018 (Closing)

The financial analysis of a company like TherapeuticsMD involves checking the three financial statements of the company in detail, of which the balance sheet is one. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our TherapeuticsMD stock analysis. Good annual results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. The TherapeuticsMD balance sheet for 2017 shows total assets of $143.22M. The company has a asset turnover ratio of 0.1. Also see: TherapeuticsMD revenue and TherapeuticsMD operating cash flow for the same year.

View latest 10 year balance sheet data to check TherapeuticsMD financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Cash127.13M131.53M64.7M51.36M54.19M1.55M-
Marketable Securities-------
Receivables4.32M4.5M3.04M2.15M1.69M--
Inventory1.48M1.07M-1.18M1.04M1.61M-
Raw Materials-------
Work In Progress-------
Finished Goods1.48M1.06M---1.12M-
Notes Receivable-------
Other Current Assets6.6M2.29M2.23M1.53M2.47M--
Total Current Assets
139.55M139.41M70.68M56.23M59.4M4.52M1.23M
Property Plant & Equipment-------
Accumulated Depreciation-------
Net Property Plant & Equipment
-------
Investment & Advances-------
Other Non-Current Assets-------
Deferred Charges-------
Intangibles3.09M2.4M1.61M1.22M---
Deposits & Other Assets--1.23M1.55M1.88M--
Total Assets
143.22M142.47M73.72M59.07M62.01M5.81M1.43M
Notes Payable------2.35M
Accounts Payable4.09M7.35M3.12M6.32M2.11M1.64M-
Current Portion Long-Term Debt-------
Current Portion Capital Leases-------
Accrued Expenses-------
Income Taxes Payable-------
Other Current Liabilities9.22M7.62M7.53M4.36M5.2M1.87M-
Total Current Liabilities
13.32M14.98M10.66M10.69M7.31M3.51M3.15M
Mortgages-------
Deferred Taxes/Income-------
Convertible Debt-------
Long-Term Debt-----3.58M-
Non-Current Capital Leases-------
Other Long-Term Liabilities-------
Total Liabilities
13.32M14.98M10.66M10.69M7.31M7.25M3.15M
Minority Interest-------
Preferred Stock-------
Common Stock Net-------
Capital Surplus516.35M436.99M282.71M182.98M135.08M50.58M15.19M
Retained Earnings-386.65M-309.7M-219.82M-134.74M-80.53M-52.11M-16.99M
Treasury Stock-------
Other Liabilities-------
Shareholders Equity129.9M127.48M63.06M48.38M54.69M-1.43M-1.71M
Total Liabilities & Shareholders Equity143.22M142.47M73.72M59.07M62.01M5.81M1.43M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Apart from balance sheet items, an investor would do well to keep track of the TherapeuticsMD stock price by looking at TherapeuticsMD historical stock prices. One can compare PE with industry average by looking at the TherapeuticsMD PE ratio chart. The common balance sheet items are:

  • Assets: TXMD total assets, which was at $143.22M for 2017 is a balance sheet item representing value of what TherapeuticsMD owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for TherapeuticsMD is $13.32M. Shareholders' equity comes under liabilities as it is money the company owes the holders of TXMD stock.

TherapeuticsMD Balance Sheet - Key Ratios

Current ratio
7.88
Debt to equity ratio
0.94
Asset turnover ratio
0.1
Receivables turnover
3.52
Price to book ratio
11.92